✦ LIBER ✦

Treatment of Pediatric Hodgkin Lymphoma

✍ Scribed by Michael R. Olson; Sarah S. Donaldson

Book ID: 107532020
Publisher: Springer
Year: 2008
Tongue: English
Weight: 210 KB
Volume: 9
Category: Article
ISSN: 1527-2729
DOI: 10.1007/s11864-008-0058-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of radiation therapy in the tre

The role of radiation therapy in the treatment of pediatric non-Hodgkin's lymphomas

✍ Steven C. Carabell; J. Robert Cassady; Howard J. Weinstein; Norman Jaffe 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 917 KB

Long-term results of the first Italian A

Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92)

✍ Marta Pillon; Maria Teresa Di Tullio; Alberto Garaventa; Simone Cesaro; Maria Ca 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## BACKGROUND Childhood B‐cell lymphomas (B‐NHLs) represent a group of aggressive malignancies that are amenable to high‐intensity chemotherapy regimens. In 1992, the Italian Association of Pediatric Hematology and Oncology (AIEOP) initiated a prospective clinical trial involving the d

Pediatric non-Hodgkin lymphoma

✍ Thomas G. Gross; Amanda M. Termuhlen 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 272 KB

Rare Pediatric Non-Hodgkin Lymphoma

✍ Bhuvana A. Setty; Amanda M. Termuhlen 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 140 KB

Pediatric non-Hodgkin’s lymphoma

✍ Thomas G. Gross; Amanda M. Termuhlen 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 179 KB

Use of cytosar in pediatric non-Hodgkin

Use of cytosar in pediatric non-Hodgkin lymphoma

✍ Sullivan, M. P. ;Ramirez, I. ;Pullen, J. ;Moore, T. ;Doering, E. J. ;Falletta, J 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Cytosar, as a component of LSAz-Lz therapy, was given in combination with thioguanine in consolidation by schedules used in acute granulocytic leukemia. Daily Cytosar injections were given for 4 days in maintenance. In an effort to increase efficacy, second generation LSAz-Lz therapy employs Cytosar